Left ventricular hypertrophy: dissociation of structural and functional effects by therapy

Area of Science:

• Cardiology
• Pharmacology
• Molecular Biology

Background:

• Essential hypertension leads to left ventricular hypertrophy (LVH) as the heart adapts to increased afterload.
• LVH presents a cardiac risk independent of hemodynamic factors.
• Antihypertensive therapy can mitigate hemodynamic alterations but its effect on independent LVH risk is a recent focus.

Purpose of the Study:

• To investigate the hemodynamic/structural dissociation of pharmacological agents in reducing cardiac mass in spontaneously hypertensive rats with LVH.
• To explore how different antihypertensive agents impact cardiac function and structure, independent of their blood pressure-lowering effects.

Main Methods:

• Utilized spontaneously hypertensive rats with established left ventricular hypertrophy.
• Administered various antihypertensive agents, including centrally active adrenolytics, angiotensin-converting enzyme (ACE) inhibitors, and calcium antagonists.
• Assessed hemodynamic and structural changes, as well as cardiac function, including Frank-Starling relationships.

Main Results:

• All tested agents (ACE inhibitors, calcium antagonists, adrenergic inhibitors) reduced cardiac mass.
• Significant differences were observed in the effects of these agents on cardiac structure and function, independent of hemodynamic changes.
• Even within ACE inhibitors, functional effects varied, impacting Frank-Starling relationships differently.

Conclusions:

• Antihypertensive agents exhibit varying abilities to reduce cardiac mass, with some acting through non-hemodynamic mechanisms.
• The choice of antihypertensive therapy can significantly impact cardiac function and potentially preserve or improve it, beyond blood pressure control.
• Further research into molecular mechanisms, such as intracellular calcium and local renin-angiotensin systems, is crucial for understanding and managing LVH.